Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

WORLD PHARMACOLOGY 2020

About World Pharmacology 2020 Conference

Dear Potential Researchers, Scientists, Industrialists & Students,

Join us for 2nd International Conference on Pharmacology and Toxicology

Date: November 19-20, 2020

Theme: Broaden the possibilities of Pharmacology and Toxicology

If you are interested to be a part of this event as a speaker or delegate!

Email: [email protected]

Call: 1-201-380-5561 (Extension No- 7005)

WhatsApp: +44 7723584563

 

ME Conferences is hosting a webinar on “2nd International Conference on Pharmacology and Toxicology” during November 19-20, 2020, with a theme of "Broaden the possibilities of Pharmacology and Toxicology" which brings you a series of fabulous researchers, scientists, industrialists etc., who will be sharing their experiences from various perspectives and addressing key questions.

The main motto is to update skills, enhance knowledge base, and networking through virtual platform.
 
During the period of travel restrictions and lockdown, why waste your time?
 
Join our webinar to share and gain knowledge on Pharmacology and Toxicology!!
 

Pharmacology is integrative of fields like biochemistry, toxicology, genetic engineering, molecular engineering and its advancement using nanotechnology. Pharma includes health care contribution to drug development and discussed research and innovative works in the pharmacy field. During this conference, the international symposiums, B2B meetings, international workshops will also be organized to discuss the specific topics in the field of pharmacology and toxicology. The conference also welcomes International exhibitions form corporate sectors to showcase the recent advancements in the tools and techniques. In all its ways World Pharmacology 2020 creates an opportunity to make partnership deals which will turn into a cent percent success meet.

Why to attend ?

On behalf of the organizing committee, we take this opportunity in extending a warm and cordial welcome to you to be a part of the Upcoming Pharmacology and Toxicology Webinar. World Pharmacology Webinar 2020 conference is scheduled during November 19-20, 2020. This conference aim is to gather the most elegant societies and industries along with the renowned and honorable persons from top universities across the globe. The World Pharmacology 2020 organizing committee is confident that participants will get benefits from this high-value scientific program. 

Target Audience of World Phramacology 2020

  • Pharmacologists
  • Toxicologists
  • Researchers
  • Clinicians
  • Oncologists
  • Ethnopharmacologists
  • Radiologists
  • Research scholars in Pharmacology
  • R&D department in pharmacy
  • Pharma research institutes
  • Forensic Professionals
  • Toxicology Professionals
  • Professors & Students from Pharmacology
  • Pharma research universities in Asia-pacific regions

Benefits of joining webinar:

 • Reduced costs and affordability
 • Access to all sessions online
 • Make new connections
 • Get your abstracts published with DOI
 • Get certified for your participation
 • Global exposure of your research
 • Increased engagement
 • Develop your business
 • Monitor your competitors activities
 • Cost effectiveness
 • Significant time saving
 • Convenience

Guidelines for Presenters

 • Each presenter will have 20-25 minutes for their presentation. 
 • Plan your talk for 15 minutes to allow for introduction and Q&A sessions at the end of your talk.
 • Ensure that you start and end your presentation on the times indicated in the program.
 • Language preference- English

Sessions/Tracks

Track 1: Pharmacokinetics and Pharmacodynamics

Pharmacology is the think about of the intuitive between drugs and the body. The two wide divisions of pharmacology are pharmacokinetics and pharmacodynamics. Pharmacokinetics (PK) alludes to the development of drugs through the body, while pharmacodynamics (PD) alludes to the body’s organic reaction to drugs. Pharmacokinetics portrays a drug’s presentation by characterizing retention, dispersion, bioavailability, digestion system, and excretion as a work of time. Pharmacodynamics depicts sedate reaction in terms of biochemical or atomic intuitive.

Track 2: Pharmacotherapeutics and Drug Toxicity

Pharmacology crosses with toxicology when the physiological response to a drug is an antagonistic impact. A harm is any substance, counting any sedate, that has the capacity to hurt a living being. Harming by and large suggests that harming physiological impacts result from presentation to pharmaceuticals, unlawful drugs, or chemicals. Harming for the most part suggests that harming physiological impacts result from introduction to pharmaceuticals, illegal drugs, or chemicals. Dug toxicity/safety appraisal is fundamental to sedate revelation and advancement. Drug-induced toxicities in liver, heart, kidney, and brain right now account for more than 70% of sedate steady loss and medicate withdrawal. Label-free procedures counting RWG and electric biosensors can be utilized to survey compound-induced cardiotoxicity, skeletal muscle hypertrophy, hepatotoxicity, and neurotoxicity.

Track 3. Drug Discovery, Development and Posology

A variety of approaches is utilized to recognize chemical compounds which will be created and showcased. The current state of the chemical and organic sciences required for pharmaceutical advancement manages that 5,000–10,000 chemical compounds must experience research facility screening for each unused medicate approved for utilize in people. The method of revealing and creating unused drugs is an extremely exorbitant and time devouring exertion. Pharmaceutical companies got to make beyond any doubt that as it were secure and strong drugs are discharged to the open. At a taken a toll of between $800 million and $1 billion, over a course of 10 to 15 a long time, each medicate experiences a exacting prepare of revelation, advancement, endorsement and at last, open utilize.

 Track 4. Novel Drug Delivery System (NDDS)

The strategy by which a medicate is conveyed can have a critical impact on its viability. A few drugs have an ideal concentration extend inside which most extreme advantage is determined, and concentrations over or underneath this extend can be poisonous or create no restorative advantage at all. On the other hand, the exceptionally moderate advance within the adequacy of the treatment of serious maladies, has recommended a developing require for a multidisciplinary approach to the conveyance of therapeutics to targets in tissues. From this, unused thoughts on controlling the pharmacokinetics, pharmacodynamics, non-specific harmfulness, immunogenicity, biorecognition, and adequacy of drugs were created. These unused techniques, regularly called medicate conveyance frameworks (DDS), are based on intrigue approaches that combine polymer science, pharmaceutics, bioconjugate chemistry, and atomic science.

  Track 5. Genetic and Molecular Toxicology

The study of gene expression has gotten to be a foundation of molecular toxicology and toxicogenomics. From a toxicological angle, constitutive expression levels of a quality can be fair as critical in deciding the result of harmfulness as the inducible expression. There are six unmistakable steps at which quality expression can be controlled; these are translation, RNA handling, RNA transport, interpretation, mRNA corruption, and control of protein action. Whereas this in general worldview of quality direction is still substantial, the complexity of hereditary direction starts for the most part at the level of translation and certain post-transcriptional occasions. A exhaustive understanding of the complexity and smoothness of quality and genome structure and their control is an fundamentally portion within the hypothesis and hone of molecular toxicology and toxicogenomics.

 Track 6. Neuro and Cardiovascular Pharmacology

The pharmacological study that deals with Cardiac and Neuronal drugs. Cardiac or Cardiovascular pharmacology reveals the cardiac medicine activities in different heart diseases that include cardiac arrhythmias, hypertension, congestive heart failure, Angina and cardiomyopathy. The neuronal pharmacology concentrates on neurological disorders and their drug pharmacological activities. There is a physiological relation between cardiac and neuropharmacology as every cardiac disorder is inter related with the nervous system. The cardiac system is internally being controlled by sympathetic and parasympathetic nervous systems.

Track 7: Neuropharmacology and Psychopharmacology

Neuropharmacology is the think about of how drugs influence cellular work within the apprehensive framework, and the neural components through which they impact conduct. There are two fundamental branches of neuropharmacology: behavioral and atomic. Behavioral neuropharmacology centers on the think about of how drugs influence human conduct (neuropsychopharmacology), counting the ponder of how sedate reliance and habit influence the human brain. Atomic neuropharmacology includes the consider of neurons and their neurochemical intelligent, with the by and large objective of creating drugs that have useful impacts on neurological work. Both areas are closely associated, since both are concerned with the intelligent of neurotransmitters, neuropeptides neuro hormones, neuromodulators, proteins, moment delivery people, co-transporters, particle channels, and receptor proteins within the central and fringe anxious frameworks. Examining these interactions, analysts are creating drugs to treat numerous diverse neurological clutters, counting torment, neurodegenerative illnesses such as Parkinson's malady and Alzheimer's illness, mental clutters, habit, and numerous others.Dose response relation in psychiatric medications

 Track 8.  Immunopharmacology and Immunotoxicology

Immunopharmacology is characterized as that portion of pharmacology that bargains with drugs acting on the safe framework and, in expansion, with the pharmacological activities of substances determined from the safe framework. In arrange to loan more honed definition to the term immunopharmacology the subject matter has been separated agreeing to clinical and down to business criteria. Immunotoxicology is the ponder of the poisonous quality of outside substances called xenobiotics and their impacts on the resistant framework. A few poisonous specialists that are known to modify the resistant framework incorporate: mechanical chemicals, overwhelming metals, agrochemicals, pharmaceuticals, drugs, bright radiation, discuss poisons and a few organic materials.

Track 9. Food and Nutritional Toxicology

Nutritional toxicology may be a claim to fame that combines the foundations and inquire about approaches of sustenance and toxicology. Numerous issues of considerable significance to wellbeing and nourishment security include intuitive of sustenance handle and necessity with the impacts of toxicologcal affect. Arrangement of these issues requires inquire about that meets the procedural and plan criteria of test sustenance and these of test toxicology. The connections may be depicted in three fundamental categories: impact of sustenance on toxicities; impact of toxicants on sustenance; and toxicities of supplements.

 Track 10. Clinical Pharmacology

Clinical pharmacology is the science of drugs in people and their ideal clinical utilize in patients. It is supported by the essential science of pharmacology, with an included center on the application of pharmacological principles and quantitative strategies within the genuine human patient's populace. It incorporates a wide scope, from the disclosure of unused target atoms to the impacts of drug usage in entirety populaces. Clinical pharmacology moreover interfaces the hole between restorative hone and research facility science. The most objective is to advance the security of medicine, maximize the medicate impacts and minimize the side impacts.

Track 11. Toxicology

Toxicology is the department of pharmacology which incorporates the think about of antagonistic impacts of drugs on the body. It bargains with the side effects, components, treatment and discovery of harming caused by diverse chemical substances. The fundamental measure is the dosage. Fundamental drugs are harms in tall dosages and a few harms are fundamental medications in moo measurements.

Track 12: Genetic toxicology

The gene toxicity is portrayed as the destructive chemical substances that harm the hereditary data within the cells. By uncovering to this kind of chemical and natural specialists comes about in epigenetic variations which decipher to assortment of infections primarily to cancer. An increment within the rate of mutational occasions in human eggs or sperms may lead to an increment within the frequency of hereditary disease and incapacity in future eras. In differentiate, impacts in physical cells don't posture a risk to future eras, because they are not hereditarily transmitted past the person in which they happen Genetic toxicology could be a department of the field of toxicology that evaluates the impacts of chemical and physical operators on the innate fabric (DNA) and on the hereditary forms of living cells.

Track 13:  Forensic toxicology

Forensic toxicology is the utilize of toxicology and disciplines such as explanatory chemistry, pharmacology and clinical chemistry to help restorative or legitimate examination of passing, harming, and medicate utilize. The essential concern for forensic toxicology isn't the lawful result of the toxicological examination or the innovation utilized, but or maybe the obtainment and elucidation of comes about. A toxicological investigation can be done to different sorts of tests. A forensic toxicologist must consider the setting of an examination, in specific any physical indications recorded, and any prove collected at a crime scene that will contract the look, such as pill bottles, powders, follow buildup, and any accessible chemicals. Given with this data and tests with which to work, the forensic toxicologist must decide which poisonous substances are show, in what concentrations, and the plausible impact of those chemicals on the individual.

Track 14:  Pharamcogenomics

Pharmacogenomics is the broader application of genomic technologies to new drug discovery and further characterization of older drugs. Recombinant DNA technology involves the artificial joining of DNA of one specie to another. E. coli is mostly used. In this way we can get huge amounts of drug in purified form which is less antigenic. Examples include GH, interferon and vaccines.

Track 15: Drug Discovery & Drug Screening

In the field of medication, biotechnology and pharmacology, drug disclosure is the method by which new drugs are found. Generally, drugs were found by recognizing the dynamic fixing from conventional cures or by fortunate disclosure, as with penicillin. More as of late, chemical libraries of engineered little particles, common items or extricates were screened in intaglio cells or entirety living beings to recognize substances that had a alluring helpful impact in a prepare known as classical pharmacology. After sequencing of the human genome permitted fast cloning and amalgamation of expansive amounts of decontaminated proteins, it has ended up common hone to utilize tall throughput screening of huge compounds libraries against separated natural targets which are hypothesized to be disease-modifying in a handle known as invert pharmacology. Hits from these screens are at that point tried in cells and after that in creatures for adequacy.

Market Analysis

The pharmaceutical industry comprises of companies that are engaged in research, development, manufacture and distribution drugs for human or veterinary use. The primary function of the research-based pharmaceutical corporations is to create value by discovering and producing effective medicines, vaccines and services that improve patients’ well-being, and can be sold in markets at a profit. As well as increasing shareholder value, this contributes significantly to the quality and protection of life and helps make the world a better place. In the past 60 years, innovation and technology have driven huge improvements in global health.

Every clinical trial in Austria must be approved by the Federal Office for Safety in Healthcare and needs a positive opinion of the ethics committee. Details on terminological definitions and on the requirements and implementation of clinical trials are set out in the Medicinal Products Act in § 2a and § 28 to § 48. The objective is to prove the effectiveness and tolerability of these forms of treatment and to improve the medical care of future patients. In principle, a distinction is made between clinical trials (intervention studies) and non-interventional studies.

Market Analysis of Global Pharmaceutical Industries

The global $1.12 trillion market in 2022, will rise at a faster clip during 2016-2020, then slow down a bit as major patent expiration take hold. It is expected that the global market declined by 1.0% in 2015 but will grow by 4.8% this year. Prescription sales excluding generics will rise 4.4% this year and expected to reach $1.006 trillion in 2022. Generics sales will increase from $73 billion in 2015 to $115 billion in 2022 and constitute 10.2% of prescription sales at that point only 0.3 percentage points more than it is now.

The global market for drug discovery technologies and products was worth $38.4 billion in 2011. This figure is projected to reach $41.4 billion in 2012 and $79 billion in 2017, a five-year compound annual growth rate (CAGR) of 13.8%. There is a need to impede serious adverse effects caused by the drugs by enhancing drug targeting through research in pharmacology.

The global revenue for single use technology reached $1.4 billion and $1.7 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.7% to nearly $3.0 billion for the period 2014-2019.

 

The fast-growing division of the pharmaceutical market includes generics and biologics. Biologics now account for over a third of all new drugs in clinical trials or awaiting FDA approval.15 U.S generic drug sales reached an estimated $70 billion, representing a quarter of the global market, due to a large number of drugs going off-patent and healthcare reforms favoring generics. Although generics make up only 22 percent of total prescription sales, its share of filled prescriptions has risen from 19 percent in 1984 to 88 percent in 2015. The research-based pharmaceutical industry is estimated to have spent nearly USD 149.8 billion globally on pharmaceutical R&D in 2015-16. Among all the industrial sectors, the research-based pharmaceutical industry has consistently invested the most in research and development, even in times of economic turmoil and monetary crisis.

Associations in USA:

  • American Pharmacist Association
  • The American Association of Pharmaceutical Scientist
  • American College of Clinical Pharmacy
  • Indo American Pharmaceutical Society
  • National Pharmaceutical Association, USA
  • International Pharmaceutical Federation
  • National Community Pharmacists Association
  • American Society of Health-System Pharmacists
  • American Association of Colleges of Pharmacy
  • Society of Critical Care Medicine
  • Royal Pharmaceutical Society
  • Pakistan American Pharmacist Association
  • Association of Accessible Medicine
  • American Society of Consultant Pharmacists
  • National Association of Chain Drug Stores
  • Joint Commission on the Accreditation of Healthcare Organizations
  • Board of Pharmacy Specialties
  • Generic Pharmaceutical Association, Washington
  • Ghanaian Pharmacists Association
  • Regulatory Affairs Professionals Society

Associations in Europe:

  • European Federation of Pharmaceutical Industries & association
  • European Association of Euro-Pharmaceutical Companies
  • European Healthcare Distribution Association
  • European Confederation of Pharmaceutical Entrepreneurs
  • Pharmaceutical Group of the European Union
  • Southeast European Pharmaceutical Association
  • British Association of European Pharmaceutical Distributors
  • European Association of Faculties in Pharmacy
  • European pharmaceutical Students’ Association
  • European and International Biotech Industry Associations
  • European Industrial Pharmacists Group
  • European Federation for Pharmaceutical Sciences
  • Pharmaceutical Care Network
  • The European Commission and pharmaceutical policy
  • International Federation of Pharmaceutical Researchers & Associations
  • Parenteral Drug Association, Europe
  • International Pharmaceutical Excipients Council
  • Canadian Healthcare Licensing Association
  • European Association of Hospital Pharmacist
  • The Association of the British Pharmaceutical Industry
  • British Pharmacological Society
  • The National Pharmacy Association
  • Pharmaceutical Society of Northern Ireland

Associations in Asia Pacific:

  • The Hong Kong Association of Pharmaceutical Industry
  • Asia Partnership Conference of Pharmaceutical Association
  • Federation of Asian Pharmaceutical Association
  • Pharmaceutical Society of Singapore
  • Indian Pharmaceutical Association
  • International Pharmaceutical Student Federation, Asia
  • Controlled Release Society
  • Indian Drug Manufacturers' Association
  • Confederation of Indian Pharmaceutical Industry
  • Bulk Drug Manufacturers Association India
  • Organization of Pharmaceutical Producers, India
  • Pharmaceuticals Export Promotion Council of India
  • Indian Pharmacist Association
  • Indian Pharmacy Council
  • Indian Pharmacy Graduates' Association
  • Indian Pharma Machinery Manufacturers Association
  • Indian Association of Pharmaceutical Scientists and Technologists

Associations in Middle East:

  • International Society of Pharmacovigilance
  • World Health Organization
  • Saudi Pharmaceutical Society
  • Middle East Medical Information Centre
  • Kuwait Pharmaceutical Association
  • Dubai Pharmaceutical Information Association
  • Turkish Pharmacists' Association
  • Pharmaceutical Industry Association of Turkey
  • Pharmaceutical Manufacturers Association of Turkey
  • International Pharmaceutical student’s Association, Turkey & Dubai
  • Emirates Pharmacist Association
  • Dubai International Pharmaceutical & Technological Association
  • Commonwealth Pharmacist Association
  • Muslim Pharmacist Association
  • Emirates Medical Association

Past Conference Report

World Pharmacology 2019

The  1st International Conference on Pharmacology and Toxicology hosted by Conference Series LLC LTD was successfully held during December 09-10, 2019, at Dubai, UAE . World Pharmacolgy 2019 marked with the attendance of the committee members, senior scientists, young researchers, business delegates and brilliant students from various countries who made this conference successful and productive.
This conference highlighted the theme “Widening the possibilities in Pharmacology and Toxicology” with the following scientific tracks:
  • Food and Nutritional Toxicology
  • Pharmacovigilance
  • Psychopharmacology and Pharmacoepidemiology
  • Pharmacotoxicology
  • Recent Advancement in Pharmacology and Toxicology
The conference proceedings were carried out through various Scientific Sessions and plenary lectures, of which the following were highlighted as Keynote presentations:
  • Title: Strategic movements, current and future competitive landscape in biologics and biosimilars  Yavuz S Silay, MaQasid Angel Investors Network, Turkey
  • Title: Targeted drug delivery is a type of intelligent drug delivery system
  • Ismail Sehic, BRAVO, Bosnia and Herzegovina
Various sessions were chaired and co-chaired by: 
  • Shazia Iqbal, Istanbul Medipol University, Turkey
  • Essam Hamied Ahmed, Istanbul Medipol University, Turkey
Conference Series LLC LTD has taken the privilege of felicitating Pharmacology  Meet 2019 Organizing Committee, and Keynote Speakers who supported the event.
The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Pharmacology Meet 2019 Conference. We are glad to inform that all accepted abstracts for the conference have been published in Conference Series LLC LTD “Journal of Pharmaceutics & Drug Delivery Research as a special issue.
We are also appreciative to all the speakers who have attended and obliged to the Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities who supported the conference by facilitating the discussion forums .With the unique feedback received from the conference, we would like to announce the commencement of the 1st International Conference on Pharmacology and Toxicology scheduled on  December 09-10, 2019, at Dubai, UAE.

Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date November 19-20, 2020

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

Journal of Clinical & Experimental Pharmacology Pharmaceutica Analytica Acta Cardiovascular Pharmacology: Open Access

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by